liothyronine sodium
- Product NDC
- 62756-590
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- liothyronine sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA091382
- Marketing category
- ANDA
- Substance
- LIOTHYRONINE SODIUM
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 62756-590-01 | 90 TABLET in 1 BOTTLE (62756-590-01) | 20230626 | | No | Historical |
| 62756-590-08 | 100 TABLET in 1 BOTTLE (62756-590-08) | 20191128 | | No | Historical |
| 62756-590-18 | 1000 TABLET in 1 BOTTLE (62756-590-18) | 20191128 | | No | Historical |
| 62756-590-83 | 30 TABLET in 1 BOTTLE (62756-590-83) | 20191128 | | No | Historical |
| 62756-590-88 | 100 TABLET in 1 BOTTLE (62756-590-88) | 20191128 | | No | Historical |
Related DailyMed Labels
| Set ID | Title | Manufacturer | Effective date | Type | Version |
|---|
| 892e63ef-3a60-45fa-b12b-d6795acc0956 | These highlights do not include all the information needed to use LIOTHYRONINE SODIUM TABLETS safely and effectively. See full prescribing information for LIOTHYRONINE SODIUM TABLETS. LIOTHYRONINE SODIUM tablets, for oral use Initial U.S. Approval: 1956 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited | 2023-10-03 | Human Prescription Drug Label | 5 |